1. Academic Validation
  2. DMN-Tre Labeling for Detection and High-Content Screening of Compounds against Intracellular Mycobacteria

DMN-Tre Labeling for Detection and High-Content Screening of Compounds against Intracellular Mycobacteria

  • ACS Omega. 2020 Feb 14;5(7):3661-3669. doi: 10.1021/acsomega.9b04173.
Henok A Sahile 1 Celine Rens 1 Tirosh Shapira 1 Raymond J Andersen 2 Yossef Av-Gay 1 1
Affiliations

Affiliations

  • 1 Division of Infectious Diseases, Department of Medicine and Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, 2350 Health Sciences Mall, Vancouver, British Columbia, Canada V6T 1Z3.
  • 2 Department of Earth, Ocean and Atmospheric Sciences, Faculty of Science, University of British Columbia, 2036 Main Mall, Vancouver, British Columbia, Canada V6T 1Z1.
Abstract

4-N,N-Dimethylamino-1,8-naphthalimide conjugate of trehalose (DMN-Tre) is a fluorogenic dye recently developed as a diagnostic tool for tuberculosis. DMN-Tre selectively labels the mycobacterial cell wall through the Ag85 Enzymes. In this work, we disclose a protocol describing the total synthesis of DMN-Tre with more than 99% purity. We further developed a protocol for in vitro and intercellular labeling of various mycobacterial strains. DMN-Tre labeling was found to be a useful tool to study in vitro and intracellular Mycobacterium tuberculosis (Mtb) physiology and as an end-point readout system in high-content image-based screening (HCS) of drug molecules. Such uses of DMN-Tre labeling provide a simple, fast, and cheap alternative to the existing, time-consuming approach that requires Mtb strains to be genetically transformed with fluorescent reporter genes.

Figures
Products